ストックスクリーナーアプリを入手
21.40
1.57%
0.33
アフターアワーズ：
21.46
0.06
+0.28%
前日終値:
$21.07
開ける：
$21.1
24時間の取引高:
4.01M
Relative Volume:
1.08
時価総額：
$3.91B
収益：
$637.78M
当期純損益:
$239.40M
株価収益率:
17.97
EPS:
1.1909
ネットキャッシュフロー:
$307.21M
1週間 パフォーマンス:
+7.32%
1か月 パフォーマンス:
-11.57%
6か月 パフォーマンス:
-58.40%
1年 パフォーマンス:
-58.80%
1日の値動き範囲:
$20.77
$21.60
1週間の範囲:
$19.40
$21.60
52週間の値動き範囲:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
名前
Doximity Inc
セクター
電話
(650) 549-4330
住所
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, HNGE
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
21.40 | 3.85B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
174.34 | 26.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
61.68 | 11.80B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
50.47 | 9.21B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
87.99 | 7.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
56.21 | 4.25B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-20 | ダウングレード | Truist | Buy → Hold |
| 2026-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2026-02-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | アップグレード | JP Morgan | Underweight → Neutral |
| 2026-01-20 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-01-08 | アップグレード | Truist | Hold → Buy |
| 2025-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-21 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-10-27 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-10-10 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-10-01 | ダウングレード | Goldman | Neutral → Sell |
| 2025-07-09 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-06-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-02-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 開始されました | Stephens | Equal-Weight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-11-15 | 開始されました | Goldman | Neutral |
| 2024-11-14 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-08-09 | アップグレード | Needham | Hold → Buy |
| 2024-07-18 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | アップグレード | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2024-01-02 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-08-09 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-08-09 | ダウングレード | Needham | Buy → Hold |
| 2023-08-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 開始されました | Wells Fargo | Overweight |
| 2022-10-24 | 開始されました | Evercore ISI | In-line |
| 2022-10-13 | 開始されました | BTIG Research | Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 開始されました | Berenberg | Buy |
| 2022-05-18 | 繰り返されました | BofA Securities | Neutral |
| 2022-05-18 | 繰り返されました | Goldman | Buy |
| 2022-05-18 | 繰り返されました | Guggenheim | Buy |
| 2022-05-18 | 繰り返されました | Jefferies | Buy |
| 2022-05-18 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 繰り返されました | Needham | Buy |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-04 | 開始されました | BofA Securities | Neutral |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2021-12-14 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-11-17 | 開始されました | Robert W. Baird | Outperform |
| 2021-11-10 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-11-10 | 繰り返されました | Goldman | Neutral |
| 2021-11-10 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 繰り返されました | Needham | Buy |
| 2021-11-10 | 繰り返されました | Piper Sandler | Overweight |
| 2021-08-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-19 | 開始されました | Goldman | Neutral |
| 2021-07-19 | 開始されました | JP Morgan | Overweight |
| 2021-07-19 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 開始されました | Piper Sandler | Overweight |
| 2021-07-19 | 開始されました | Raymond James | Outperform |
| 2021-07-19 | 開始されました | SVB Leerink | Outperform |
| 2021-07-19 | 開始されました | William Blair | Outperform |
すべてを表示
Doximity Inc (DOCS) 最新ニュース
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - AOL.com
Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN
Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN
Workday and Doximity Shares Are Soaring, What You Need To Know - Yahoo Finance
Doximity, Inc. (DOCS) Investigation: Bronstein, Gewirtz & Grossma - The National Law Review
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet? - Yahoo Finance
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
Doximity: A Strong Contender or Vulnerable to Disruption? - AOL.com
Ex-Doximity Exec Gets 2 Years For Insider Trading Scheme - Law360
Former Doximity executive sentenced in US to prison for insider trading - MLex
Doximity’s AI Investment Year Has Arrived: Is Doximity Stock Undervalued at $20 or Not - TIKR.com
Doximity Company Profile & Introduction - Moomoo
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Doximity, Inc. (DOCS) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Doximity, Inc. (DOCS) Investors to Inquire about Securities Investigation - ACCESS Newswire
Doximity's (NYSE:DOCS) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Doximity, Inc. (DOCS) And Encourages Investors to Reach Out - ACCESS Newswire
Lawsuit probes Doximity over AI cost impact and revenue miss, shares drop 23%. - Pluang
Doximity AI Push Reshapes Healthcare Tech On Russell 1000 - Kalkine Media
Doximity, Inc. (DOCS) Stock Report: Analyst Ratings Point To A Promising 26% Upside - DirectorsTalk Interviews
Can Russell 1000 Pressure Weigh on Doximity Shares? - Kalkine Media
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - The Motley Fool
Doximity’s SWOT analysis: stock faces pressure from AI spending, slowing growth - Investing.com Nigeria
Doximity shares hit record low as soft guidance and AI margin pressures spark 25% plunge - MSN
Baird downgrades Doximity (DOCS) - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Doximity, Inc. (DOCS) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Doximity forecasts fiscal 2027 revenue of $664M-$676M amid 'AI investment year' and softer pharma ad visibility - MSN
Handelsbanken Fonder AB Sells 315,900 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity to Present at the William Blair 46th Annual Growth Stock Conference - 01net
5 Revealing Analyst Questions From Doximity’s Q1 Earnings Call - Yahoo Finance
AI Reliance Poses Growing Operational, Regulatory, and Reputational Risks for Doximity - TipRanks
Doximity Leadership Shift And AI Push Reframe Growth And Valuation Outlook - Yahoo Finance
Stock market today: S&P 500, Dow, Nasdaq futures gain as Trump clears NVDA's H200 sales to China—Cisco Systems, Doximity in focus (updated) - MSN
Is It Time To Reassess Doximity (DOCS) After Its Sharp Share Price Slide? - simplywall.st
1,246 Doximity (DOCS) shares withheld to cover RSU taxes for interim PFO - Stock Titan
Doximity (NYSE: DOCS) CEO granted PSUs while shares withheld for tax - Stock Titan
Doximity (DOCS) outlines physician network, Clinical AI Suite and main business risks - Stock Titan
Why Are Doximity (DOCS) Shares Soaring Today - Yahoo Finance
J.P. Morgan Upgrades Doximity(DOCS.US) to Hold Rating, Cuts Target Price to $28 - Moomoo
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Doximity (DOCS) Q1 CY2026 Deep Dive: AI Investments Accelerate Amid Macro and Policy Headwinds - Yahoo Finance
Why Doximity (DOCS) Shares Are Sliding Today - Yahoo Finance
Northwestern Mutual Wealth Management Co. Purchases 1,298,492 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Is Down 27.0% After Softer 2027 Outlook And Higher AI SpendWhat's Changed - Sahm
Doximity Stock Hits Day Low of $17.16 Amid Price Pressure - Markets Mojo
Another Wall Street analyst slashes Doximity stock price outlook - thestreet.com
Doximity Inc (DOCS) 財務データ
収益
当期純利益
現金流量
EPS
2.68%
0.37%
大文字化:
|
ボリューム (24 時間):